A Case of NSAID- Responsive and Rapidly-resolving Fibrous Histiocytoma

Pediatric fibroblastic, myofibroblastic, and fibrohistiocytic tumors comprise a spectrum of neoplasms of mesenchymal origin. They account for approximately 12% of soft tissue lesions in the pediatric population, and they can be benign, intermediate or locally aggressive, and Malignant subtypes. In a diffuse non-skin involving fibrous histiocytoma with inflammatory cells, a trial of said can be considered